Sanofi Announces Ambitious $1 Billion Investment to Enhance Manufacturing Capabilities in China
6 months ago
In a significant move aimed at boosting its production capabilities, French pharmaceutical giant Sanofi has unveiled plans for a substantial $1 billion investment in China. This initiative is designed to enhance the company's manufacturing footprint within one of the world's most dynamic markets, further solidifying its operational base in Asia.
Continue reading
AstraZeneca's Ambitious Venture in China Under Scrutiny Amid CEO Investigation
7 months ago
AstraZeneca, the British pharmaceutical giant, is currently facing an intense spotlight as both its strategic expansion in China and the integrity of its chief executive officer (CEO) come under investigation. This development raises significant questions about the company's future in one of the world's largest pharmaceutical markets.
Continue reading